Filing Details
- Accession Number:
- 0001213900-22-020314
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-18 11:46:50
- Reporting Period:
- 2022-04-14
- Accepted Time:
- 2022-04-18 11:46:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1728328 | Inmed Pharmaceuticals Inc. | INM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1817882 | A Eric Adams | C/O Inmed Pharmaceuticals Inc. 310-815 West Hastings St. Vancouver A1 V6C1B4 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-14 | 14,160 | $0.89 | 59,003 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
